High dose of atorvastatin for the treatment of contrast-induced nephropathy after carotid artery stenting

American Journal of Therapeutics

Volumn 24, Issue 6, 2015, Pages e718-e722

  Fu, Maolin ^a   Dai, Weizheng ^a   Ye, Yingan ^a   Lu, Qiuxiang ^a   He, Wenqin ^a  

^a No 534 Hospital of PLA   (China)

Author keywords

Atorvastatin; Carotid artery stenting; Contrast induced nephropathy; Dose

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATORVASTATIN; C REACTIVE PROTEIN; CREATINE KINASE; CREATININE; IOPROMIDE; CONTRAST MEDIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CAROTID ARTERY STENTING; CHRONIC KIDNEY FAILURE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; UREA NITROGEN BLOOD LEVEL; AGED; BLOOD; CAROTID ARTERY; CHEMICALLY INDUCED; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; DEVICES; DIAGNOSTIC IMAGING; DOSE RESPONSE; EVALUATION STUDY; INCIDENCE; KIDNEY; KIDNEY DISEASE; PATHOPHYSIOLOGY; PROCEDURES; STENT; SURGERY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ALANINE TRANSAMINASE; ANGIOPLASTY, BALLOON, CORONARY; ASPARTATE AMINOTRANSFERASES; ATORVASTATIN; BLOOD UREA NITROGEN; C-REACTIVE PROTEIN; CAROTID ARTERIES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATINE KINASE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; STENTS; TREATMENT OUTCOME;

EID: 84952705821     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0000000000000407     Document Type: Article

References (22)

1. Aurelio A, Durante A. Contrast-induced nephropathy in percutaneous coronary interventions: pathogenesis, risk factors, outcome, prevention and treatment. Cardiology. 2014;128:62-72.
2. Turan B, Erkol A, Göl M, et al. Effect of contrast-induced nephropathy on the long-Term outcome of patients with Non-ST segment elevation myocardial infarction. Cardiorenal Med. 2015;5:116-124.
3. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol. 2001;12:3-9.
4. Gao F, Zhou YJ, Zhu X, et al. C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol. 2011;34:203-210.
5. Jian-Wei Z, Yu-Jie Z, Shu-Jun C, et al. Impact of preprocedural high-sensitivity C-reactive protein on contrastinduced nephropathy in patients undergoing primary percutaneous coronary intervention. Angiology. 2014;65: 402-407.
6. Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. Br J Radiol. 2014;87:20130738.
7. Liu Y, Tan N, Zhou YL, et al. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012;25:332-340.
8. Trani C, Porto I, Tommasino A, et al. Baseline inflammatory status and long-Term changes in renal function after percutaneous renal artery stenting: A prospective study. Int J Cardiol. 2013;167:1006-1011.
9. Abaci O, Arat Ozkan A, Kocas C, et al. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography. Am J Cardiol. 2015;115:867-871.
10. Chanin JM, Yang DC, Haider MA, et al. Impact of chronic statin therapy on Postprocedural contrastinduced nephropathy in patients undergoing Non-Emergent percutaneous coronary intervention. J Invasive Cardiol. 2015. pii: JIC2015515-2.
11. Leoncini M, Toso A, Maioli M, et al. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrastinduced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study. Am Heart J. 2014;168:792-797.
12. Liu YH, Liu Y, Duan CY, et al. Statins for the prevention of contrast-induced nephropathy after coronary Angiography/Percutaneous interventions: A meta-Analysis of randomized controlled trials. J Cardiovasc Pharmacol Ther. 2015;20:181-192.
13. Peruzzi M, De Luca L, Thomsen HS, et al. A network meta-Analysis on randomized trials focusing on the preventive effect of statins on contrast-induced nephropathy. Biomed Res Int. 2014;2014:213239.
14. Singh N, Lee JZ, Huang JJ, et al. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-Analysis. Open Heart. 2014;1:e000127.
15. Ukaigwe A, Karmacharya P, Mahmood M, et al.Meta-Analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Am J Cardiol. 2014;114:1295-1302.
16. Alonso A, Lau J, Jaber BL, et al. Prevention of radiocontrast nephropathy with N-Acetylcysteine in patients with chronic kidney disease: A meta-Analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1-9.
17. Patti G, Nusca A, Chello M, et al. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-Term outcome in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2008;101:279-285.
18. Chello M, Goffredo C, Patti G, et al. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. Eur J Cardiothorac Surg. 2005;28:805-810.
19. Khanal S, Attallah N, Smith DE, et al. Statin therapy reduces contrast-induced nephropathy: An analysis of contemporary percutaneous interventions. Am J Med. 2005;118:843-849.
20. Park JK, Möller DN, Mervaala EM, et al. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure-And cholesterol-lowering effects. Kidney Int. 2000;58:1420-1430.
21. Zhang BC, Li WM, Xu YW. High-dose statin pretreatment for the prevention of contrast-induced nephropathy: A meta-Analysis. Can J Cardiol. 2011;27:851-858.
22. Amarenco P, Callahan A III, Campese VM, et al. Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014;45:2974-2982.